WOONSOCKET, R.I., Nov. 11, 2020 /PRNewswire/ — CVS Health Corporation (NYSE: CVS) today announced that Daniel Finke has been named Executive Vice President, CVS Health and President, Health Care Benefits Segment (HCB) effective February 1, 2021. Finke will succeed Karen S. Lynch, who will become President and CEO of CVS Health in February. HCB provides solutions to employers and government businesses, serving more than 34 million members.
“Dan’s dedication to the health of our members and passion around addressing health care disparities make him the ideal person to take the Health Care Benefits segment forward,” said Lynch. “Dan has a track record of driving growth, delivering strong operating improvements and bringing customer-driven innovations to the market.”
Finke brings more than 25 years of diverse health care experience to the company. He joined Aetna in 2014 and most recently has been leading the Commercial Business and Markets organization. Prior to his current role, he held leadership roles in network and clinical services and was a key leader on the transformation team during the integration with CVS Health. Before joining Aetna, Finke served as President and Chief Operating Officer of EmblemHealth, and previously spent more than a decade at Anthem in various national executive roles in healthcare operations, government programs and pharmacy benefit management.
“It’s an honor to lead the Health Care Benefits segment and to support our customers, members, providers and colleagues,” said Finke. “I’m committed to simplifying the health experience for members using digital solutions and bringing to market CVS Health integrated products that demonstrate our unique ability to serve the needs of our customers.”
Finke will report directly to Lynch and will be a member of the company’s executive team. Active in the community, Finke has served on multiple boards including the Alzheimer’s Association of New York City, The Battery Park Conservancy, America’s Health Insurance Plans, and the New York Health Plan Association. Dan is also a registered pharmacist.
About CVS Health
CVS Health is a different kind of health care company. We are a diversified health services company with nearly 300,000 employees united around a common purpose of helping people on their path to better health. In an increasingly connected and digital world, we are meeting people wherever they are and changing health care to meet their needs. Built on a foundation of unmatched community presence, our diversified model engages one in three Americans each year. From our innovative new services at HealthHUB® locations, to transformative programs that help manage chronic conditions, we are making health care more accessible, more affordable…and simply better. Learn more about how we’re transforming health at www.cvshealth.com.
Media contact
T.J. Crawford
Vice President, External Affairs
212-457-0583
crawfordt2@aetna.com
Investor contact
Valerie Haertel
Senior Vice President, Investor Relations
401-770-4050
valerie.haertel@cvshealth.com
Regulators authorized AstraZeneca’s coronavirus vaccine for use in adults throughout the European Union on Friday, amid criticism the bloc is not moving fast enough to vaccinate its population.
WASHINGTON (AP) — A former FBI lawyer was sentenced to probation for altering an email that the Justice Department relied on during its surveillance of an aide to President Donald Trump during the Russia investigation.
MADISON, Wis. (AP) — Democratic Gov. Tony Evers lashed out Friday at rival Republicans who tried to repeal his statewide mask mandate, saying killing the order would be a ridiculous move comparable to abolishing speed limits.
COLUMBIA, S.C. (AP) — As some conservatives in South Carolina celebrated getting a bill that would ban almost all abortions in the state past a legislative barrier and likely becoming law, they said they are not finished trying to end all abortions.
A Moscow court on Friday put the brother and several allies of Russian opposition leader Alexei Navalny under house arrest for two months as authorities sought to stymie more protests over the jailing of the top Kremlin foe.